1072238

Axogen Corporation — FEI 3011006318

Inspection Details

Classification
Voluntary Action Indicated (VAI) (VAI)
End Date
November 20, 2018
Fiscal Year
2019
Product Type
Biologics
Project Area
Human Cellular, Tissue, and Gene Therapies
Location
Burleson, TX (United States)

Citations

IDCFRDescription
1244721 CFR 1271.290(b)Establishing a system